CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 32.46

Change

+0.45 (+1.39)%

Market Cap

USD 0.28B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.94 (-2.04%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-2.12 (-2.12%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.60 (-2.51%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.38 (-2.82%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.15 (-2.68%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.60 (-2.60%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.30 (-2.35%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.39 (+0.70%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.15 (-1.45%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.10 (+0.08%)

USD 12.26B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.09% 98% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.09% 98% N/A 94% A
Trailing 12 Months  
Capital Gain 53.26% 98% N/A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.26% 98% N/A 96% N/A
Trailing 5 Years  
Capital Gain 76.47% 60% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.47% 61% D- 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 3.27% 37% F 39% F
Dividend Return 3.51% 37% F 38% F
Total Return 0.24% 24% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.73% 21% F 33% F
Risk Adjusted Return 17.79% 27% F 31% F
Market Capitalization 0.28B 59% D- 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.